Coston McIsaac & Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60
Closed -$1K 761
2024
Q4
$1K Hold
60
﹤0.01% 708
2024
Q3
$1K Hold
60
﹤0.01% 709
2024
Q2
$1K Hold
60
﹤0.01% 689
2024
Q1
$1K Hold
60
﹤0.01% 679
2023
Q4
$1K Hold
60
﹤0.01% 674
2023
Q3
$1K Hold
60
﹤0.01% 676
2023
Q2
$2K Hold
60
﹤0.01% 681
2023
Q1
$1K Hold
60
﹤0.01% 746
2022
Q4
$1K Hold
60
﹤0.01% 716
2022
Q3
$1K Hold
60
﹤0.01% 635
2022
Q2
$2K Buy
+60
New +$2.21K ﹤0.01% 415

Other funds holding CC

Coston McIsaac & Partners's CC Position: Q1 2025 in Review

Coston McIsaac & Partners sold out of Chemours (CC) in Q1 2025, closing a stake of 60 shares — an estimated $1K sold.

Coston McIsaac & Partners first reported a position in CC in Q2 2022 and held it in 11 quarters. The position peaked at $2K in Q2 2023. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

  • Coston McIsaac & Partners reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
  • Coston McIsaac & Partners sold 60 Chemours shares in Q1 2025, an estimated $1K.
  • Coston McIsaac & Partners first reported a position in Chemours in Q2 2022 and held it in 11 quarters.
  • Coston McIsaac & Partners's Chemours position peaked at $2K in Q2 2023.
  • 419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Coston McIsaac & Partners's 13F filing for Q1 2025, filed 13 May 2025.